BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38477791)

  • 1. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
    Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
    J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of low and very low bone mineral density in long-term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction.
    Nadeau G; Samoilenko M; Fiscaletti M; Veilleux LN; Curnier D; Laverdière C; Sinnett D; Krajinovic M; Lefebvre G; Alos N
    Pediatr Blood Cancer; 2024 May; ():e31047. PubMed ID: 38736190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
    Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
    Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).
    Kaste SC; Qi A; Smith K; Surprise H; Lovorn E; Boyett J; Ferry RJ; Relling MV; Shurtleff SA; Pui CH; Carbone L; Hudson MM; Ness KK
    Pediatr Blood Cancer; 2014 May; 61(5):885-93. PubMed ID: 24395288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.
    Lequin MH; van der Shuis IM; Van Rijn RR; Hop WC; van ven Huevel-Eibrink MM; MuinckKeizer-Schrama SM; van Kuijk C
    J Clin Densitom; 2002; 5(2):167-73. PubMed ID: 12110760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study.
    Ward LM; Ma J; Lang B; Ho J; Alos N; Matzinger MA; Shenouda N; Lentle B; Jaremko JL; Wilson B; Stephure D; Stein R; Sbrocchi AM; Rodd C; Lewis V; Israels S; Grant RM; Fernandez CV; Dix DB; Cummings EA; Couch R; Cairney E; Barr R; Abish S; Atkinson SA; Hay J; Rauch F; Moher D; Siminoski K; Halton J;
    J Bone Miner Res; 2018 Aug; 33(8):1435-1443. PubMed ID: 29786884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
    van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
    J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Rohani F; Arjmandi Rafsanjani Kh; Bahoush G; Sabzehparvar M; Ahmadi M
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):535-540. PubMed ID: 28345842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.
    Gurney JG; Kaste SC; Liu W; Srivastava DK; Chemaitilly W; Ness KK; Lanctot JQ; Ojha RP; Nottage KA; Wilson CL; Li Z; Robison LL; Hudson MM
    Pediatr Blood Cancer; 2014 Jul; 61(7):1270-6. PubMed ID: 24585546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders.
    Ward LM; Ma J; Robinson ME; Scharke M; Ho J; Houghton K; Huber A; Scuccimarri R; Barsalou J; Roth J; Shenouda N; Matzinger MA; Lentle B; Jaremko JL; Koujok K; Watanabe Duffy K; Stein R; Sbrocchi AM; Rodd C; Miettunen PM; LeBlanc CMA; Larche M; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Sykes E; Konji VN; Rauch F; Siminoski K; Lang B
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5195-e5207. PubMed ID: 34232311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia.
    Mostoufi-Moab S; Kelly A; Mitchell JA; Baker J; Zemel BS; Brodsky J; Long J; Leonard MB
    Bone; 2018 Jul; 112():128-135. PubMed ID: 29679731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
    Verwaaijen EJ; Ma J; de Groot-Kruseman HA; Pieters R; van der Sluis IM; van Atteveld JE; Halton J; Fernandez CV; Hartman A; de Jonge R; Lequin MH; Te Winkel ML; Alos N; Atkinson SA; Barr R; Grant RM; Hay J; Huber AM; Ho J; Jaremko J; Koujok K; Lang B; Matzinger MA; Shenouda N; Rauch F; Rodd C; van den Heuvel-Eibrink MM; Pluijm SMF; Ward LM;
    J Bone Miner Res; 2021 Dec; 36(12):2290-2299. PubMed ID: 34610647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Phan V; Blydt-Hansen T; Feber J; Alos N; Arora S; Atkinson S; Bell L; Clarson C; Couch R; Cummings EA; Filler G; Grant RM; Grimmer J; Hebert D; Lentle B; Ma J; Matzinger M; Midgley J; Pinsk M; Rodd C; Shenouda N; Stein R; Stephure D; Taback S; Williams K; Rauch F; Siminoski K; Ward LM;
    Osteoporos Int; 2014 Feb; 25(2):627-37. PubMed ID: 23948876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
    Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
    Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation.
    Mostoufi-Moab S; Brodsky J; Isaacoff EJ; Tsampalieros A; Ginsberg JP; Zemel B; Shults J; Leonard MB
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3584-92. PubMed ID: 22865901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.
    Shalmiev A; Nadeau G; Aaron M; Ouimet-Grennan E; Drouin S; Bertout L; Beaulieu P; St-Onge P; Veilleux LN; Rauch F; Rezgui A; Petrykey K; Laverdière C; Sinnett D; Alos N; Krajinovic M
    Pharmacogenomics J; 2022 Feb; 22(1):19-24. PubMed ID: 34446917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.